pd 169316 has been researched along with thapsigargin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Bao, S; Ladenson, JH; Song, H; Tan, M; Turk, J; Wohltmann, M | 1 |
2 other study(ies) available for pd 169316 and thapsigargin
Article | Year |
---|---|
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Group VIA PLA2 (iPLA2β) is activated upstream of p38 mitogen-activated protein kinase (MAPK) in pancreatic islet β-cell signaling.
Topics: Animals; Apoptosis; Arachidonic Acid; Cell Line, Tumor; Ceramides; Dose-Response Relationship, Drug; Endoplasmic Reticulum Stress; Enzyme Activation; Gene Expression Regulation, Enzymologic; Glucose; Group VI Phospholipases A2; Imidazoles; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Mice; Naphthalenes; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyrones; Rats; rho GTP-Binding Proteins; Signal Transduction; Thapsigargin | 2012 |